These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37725224)

  • 21. Efficacy of Immediate Lymphatic Reconstruction in Prevention of Breast Cancer-Related Lymphedema.
    Le NK; Liu L; Jesus Cruz R; Parikh J; Rotatori RM; Wainwright DJ; Weinstein B; Tavares T; Panetta NJ
    Ann Plast Surg; 2023 Jun; 90(6S Suppl 4):S363-S365. PubMed ID: 36913564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relation Between Characteristics of Indocyanine Green Lymphography and Development of Breast Cancer-Related Lymphedema.
    Thomis S; Ronsse S; Bechter-Hugl B; Fourneau I; Devoogdt N
    Lymphat Res Biol; 2024 Oct; 22(5):248-254. PubMed ID: 39253841
    [No Abstract]   [Full Text] [Related]  

  • 23. Advances in the prevention and treatment of breast cancer-related lymphedema.
    Donahue PMC; MacKenzie A; Filipovic A; Koelmeyer L
    Breast Cancer Res Treat; 2023 Jul; 200(1):1-14. PubMed ID: 37103598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk prediction models for breast cancer-related lymphedema: A systematic review and meta-analysis.
    Shen A; Wei X; Zhu F; Sun M; Ke S; Qiang W; Lu Q
    Eur J Oncol Nurs; 2023 Jun; 64():102326. PubMed ID: 37137249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective, early longitudinal assessment of lymphedema-related quality of life among patients with locally advanced breast cancer: The foundation for building a patient-centered screening program.
    Gandhi A; Xu T; DeSnyder SM; Smith GL; Lin R; Barcenas CH; Stauder MC; Hoffman KE; Strom EA; Ferguson S; Smith BD; Woodward WA; Perkins GH; Mitchell MP; Garner D; Goodman CR; Aldrich M; Travis M; Lilly S; Bedrosian I; Shaitelman SF
    Breast; 2023 Apr; 68():205-215. PubMed ID: 36863241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk-of-bias assessment of the randomized clinical trials and systematic reviews on surgical treatments for breast cancer-related lymphedema: A mapping review.
    Al-Sakkaf AM; Bonfill X; Ardiles-Ruesjas S; Bendersky-Kohan J; Sola I; Masia J
    J Plast Reconstr Aesthet Surg; 2023 Sep; 84():134-146. PubMed ID: 37329747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of axillary surgery and radiotherapeutic strategy on the risk of lymphedema and upper extremity dysfunction in early breast cancer patients.
    Zheng SY; Chen CY; Qi WX; Cai G; Xu C; Cai R; Qian XF; Shen KW; Cao L; Chen JY
    Breast; 2023 Apr; 68():142-148. PubMed ID: 36764019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and incidence of cancer related lymphedema in low and middle-income countries: a systematic review and meta-analysis.
    Torgbenu E; Luckett T; Buhagiar MA; Chang S; Phillips JL
    BMC Cancer; 2020 Jun; 20(1):604. PubMed ID: 32600278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of evidence supporting the role of acupuncture for breast cancer-related lymphoedema: an overview of systematic reviews and meta-analyses.
    Wang L; Du X; Hu P; Zhang Y; Yao M; Che X
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16669-16678. PubMed ID: 37721568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for the clinical effectiveness of decongestive lymphoedema treatment for breast cancer-related arm lymphoedema, a systematic review.
    Jeffs E; Ream E; Taylor C; Purushotham A; Bick D
    Support Care Cancer; 2024 Aug; 32(8):568. PubMed ID: 39093326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and risk factors of breast cancer-related lymphedema in Korea: a nationwide retrospective cohort study.
    Ahn HR; Jeong HE; Jeong C; Kang SY; Jung SH; Youn HJ; Kim JS
    Int J Surg; 2024 Jun; 110(6):3518-3526. PubMed ID: 38477155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention and Treatment of Lymphedema in Breast Cancer.
    McEvoy MP; Feldman S
    Adv Surg; 2024 Sep; 58(1):65-77. PubMed ID: 39089787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occurrence of breast-cancer-related lymphedema after reverse lymphatic mapping and selective axillary dissection versus standard surgical treatment of axilla: A two-arm randomized clinical trial.
    Gennaro M; Maccauro M; Mariani L; Listorti C; Sigari C; De Vivo A; Chisari M; Maugeri I; Lorenzoni A; Aliberti G; Scaperrotta GP; Caraceni A; Pruneri G; Folli S
    Cancer; 2022 Dec; 128(24):4185-4193. PubMed ID: 36259883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction models for breast cancer-related lymphedema: a systematic review and critical appraisal.
    Lin Q; Yang T; Yongmei J; Die YM
    Syst Rev; 2022 Oct; 11(1):217. PubMed ID: 36229876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantifying the Impact of Axillary Surgery and Nodal Irradiation on Breast Cancer-Related Lymphedema and Local Tumor Control: Long-Term Results From a Prospective Screening Trial.
    Naoum GE; Roberts S; Brunelle CL; Shui AM; Salama L; Daniell K; Gillespie T; Bucci L; Smith BL; Ho AY; Taghian AG
    J Clin Oncol; 2020 Oct; 38(29):3430-3438. PubMed ID: 32730184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast Cancer-Related Lymphedema (BCRL) and Bioimpedance Spectroscopy: Long-Term Follow-Up, Surveillance Recommendations, and Multidisciplinary Risk Factors.
    Jeffers EJ; Wagner JL; Korentager SS; Larson KE; Balanoff CR; Baker J; Chollet-Hinton L; Kilgore LJ
    Ann Surg Oncol; 2023 Oct; 30(10):6258-6265. PubMed ID: 37535267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can Acupuncture be a Part of the Treatment for Breast Cancer-Related Lymphedema? A Systematic Review of the Safety and Proposed Model for Care.
    Kim JK; Loo C; Kim JS; Pranskevich C; Gordon OK
    Lymphology; 2023; 56(1):27-39. PubMed ID: 38019877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Axillary Lateral Vessel Thoracic Junction Is Not an Organ at Risk for Breast Cancer-Related Lymphedema.
    Healy E; Beyer S; Jhawar S; White JR; Bazan JG
    Int J Radiat Oncol Biol Phys; 2023 Oct; 117(2):452-460. PubMed ID: 37059233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical feasibility of Axillary Reverse Mapping and its influence on breast cancer related lymphedema: a systematic review.
    Gebruers N; Tjalma WA
    Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():117-22. PubMed ID: 27019287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors and prediction model for persistent breast-cancer-related lymphedema: a 5-year cohort study.
    Penn IW; Chang YC; Chuang E; Chen CM; Chung CF; Kuo CY; Chuang TY
    Support Care Cancer; 2019 Mar; 27(3):991-1000. PubMed ID: 30105666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.